Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Summary: The goal of this study was to determine the temperature coefficient (QIO) for canine CMR02 at tem peratures below 14°C. Eight dogs were anesthetized with halothane for surgical preparation. The animals were placed on total cardiopulmonary bypass and CBF was measured by direct sagittal sinus outflow. Duplicate mea surements were taken at 37, 13, and 7°C. The EEG be came isoelectric at a temperature of 12.0 ± 0.8°C. The QIO between 13 and 7°C was 2.19 ± 0.59. With rewarming to 37°C, cerebral metabolic variables returned to control It is commonly assumed that the basis for hypo thermia-induced cerebral protection is metabolic suppression. If one assumes that the temperature coefficient (QIO ) for CMR02 is similar to that for most biologic reaction rates of between 2.0 and 3.0 (Harper, 1973), the magnitude of protection clini cally observed at 15-18°C (Tharion et aI., 1982) ex ceeds that which would be predicted on a metabolic basis alone.In two previous studies we examined the effect of temperature on canine CMR02 over the tempera ture range of 14-37°C and demonstrated that the relationship is a complex one, resulting from the combined direct effect of temperature on biologic reaction rates and the effect this has on cerebral function as reflected by the EEG (Steen et aI., 1983;Michenfelder and Milde, 1991 877 levels. Brain biopsies taken at the end of the study yielded normal values for brain energy stores. We con clude that the QIO for CMR02 at temperatures between 7 and 37"C can be profoundly affected by the state of cere bral function as reflected by the EEG. In the absence of EEG activity, an expected QIO value of 2.2 reflects only the direct effect of temperature on the rates of biologic reactions. Key Words: Cerebral blood flow-Cerebral metabolic rate for oxygen-Cerebral protection Hypothermia.progresses from a near normal pattern to an isoelec tric one. Such a Q10 would fully explain the proven brain protection at 15-18°C.The present study was pursued to test the hy pothesis that the CMR02 effects of hypothermia re vert to a simple exponential relationship at and be low temperatures associated with an isoelectric EEG (below 14°C), resulting in a Q,o value of near 2.0. We are unaware of any other reports concerned with cerebral metabolic rates at temperatures below 14°C. METHODSThe protocol was reviewed and approved by the insti tutional animal care and use committee. Eight unmedi cated, fasting adult mongrel dogs, weighing 17.5 ± 2.2 kg (mean ± SD), were studied. Dogs were anesthetized with halothane 3-4% inspired followed by muscle paralysis with pancuronium 0.2 mg kg -I i. v. and intubation of the trachea. Ventilation was controlled to maintain P ac02 at 35-40 mm Hg. Anesthesia was maintained with halothane 1% (end-expired) in nitrogen and oxygen which were ad justed to maintain Pa02 at 100--150 mm Hg.The preparation of the animals for the study was iden tical to that previously described in detail (Michenfelder and Milde, 1991). In brief, CBF was measured by a sag ittal sinus outflow method (Mic...
Summary: The goal of this study was to determine the temperature coefficient (QIO) for canine CMR02 at tem peratures below 14°C. Eight dogs were anesthetized with halothane for surgical preparation. The animals were placed on total cardiopulmonary bypass and CBF was measured by direct sagittal sinus outflow. Duplicate mea surements were taken at 37, 13, and 7°C. The EEG be came isoelectric at a temperature of 12.0 ± 0.8°C. The QIO between 13 and 7°C was 2.19 ± 0.59. With rewarming to 37°C, cerebral metabolic variables returned to control It is commonly assumed that the basis for hypo thermia-induced cerebral protection is metabolic suppression. If one assumes that the temperature coefficient (QIO ) for CMR02 is similar to that for most biologic reaction rates of between 2.0 and 3.0 (Harper, 1973), the magnitude of protection clini cally observed at 15-18°C (Tharion et aI., 1982) ex ceeds that which would be predicted on a metabolic basis alone.In two previous studies we examined the effect of temperature on canine CMR02 over the tempera ture range of 14-37°C and demonstrated that the relationship is a complex one, resulting from the combined direct effect of temperature on biologic reaction rates and the effect this has on cerebral function as reflected by the EEG (Steen et aI., 1983;Michenfelder and Milde, 1991 877 levels. Brain biopsies taken at the end of the study yielded normal values for brain energy stores. We con clude that the QIO for CMR02 at temperatures between 7 and 37"C can be profoundly affected by the state of cere bral function as reflected by the EEG. In the absence of EEG activity, an expected QIO value of 2.2 reflects only the direct effect of temperature on the rates of biologic reactions. Key Words: Cerebral blood flow-Cerebral metabolic rate for oxygen-Cerebral protection Hypothermia.progresses from a near normal pattern to an isoelec tric one. Such a Q10 would fully explain the proven brain protection at 15-18°C.The present study was pursued to test the hy pothesis that the CMR02 effects of hypothermia re vert to a simple exponential relationship at and be low temperatures associated with an isoelectric EEG (below 14°C), resulting in a Q,o value of near 2.0. We are unaware of any other reports concerned with cerebral metabolic rates at temperatures below 14°C. METHODSThe protocol was reviewed and approved by the insti tutional animal care and use committee. Eight unmedi cated, fasting adult mongrel dogs, weighing 17.5 ± 2.2 kg (mean ± SD), were studied. Dogs were anesthetized with halothane 3-4% inspired followed by muscle paralysis with pancuronium 0.2 mg kg -I i. v. and intubation of the trachea. Ventilation was controlled to maintain P ac02 at 35-40 mm Hg. Anesthesia was maintained with halothane 1% (end-expired) in nitrogen and oxygen which were ad justed to maintain Pa02 at 100--150 mm Hg.The preparation of the animals for the study was iden tical to that previously described in detail (Michenfelder and Milde, 1991). In brief, CBF was measured by a sag ittal sinus outflow method (Mic...
The perfusionist must be familiar with the patient's original diagnosis, catheterization lab interventions, previous surgeries, and current needs when developing the bypass plan. The following are major considerations for management of the patient during cardiopulmonary bypass. Please refer to Chapter 6 for defect-specific considerations.The care team must have a reasonably standardized communication plan for the bypass run [1][2][3]. This includes standardizing to closed-loop communication for certain anesthesia, surgical, and cardiopulmonary bypass (CPB) commands, notifications, and/or concerns. Each communication should be verbally acknowledged per the team standard (either repeated back or with another affirmation) to ensure the information is properly delivered and handled. This technique is essential for bypass safety and is used at most centers to announce checkpoints during the case.Common bypass-related checkpoints where closedloop communication among the team is essential include the following: • Heparin in • ACT running • Bypass lines clamped and ready for division at the field • Pump suckers on (with suckers and vent line tested under saline at field)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.